{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:44:15Z","timestamp":1788335055002,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tcmonline.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.tcm.2016.03.014","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T20:42:05Z","timestamp":1459802525000},"page":"597-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Amiodarone and dronedarone: An update"],"prefix":"10.1016","volume":"26","author":[{"given":"Mate","family":"Vamos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Hohnloser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2016.03.014_bib1","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2016.03.014_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archinte.166.7.719","article-title":"Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials","volume":"166","author":"Lafuente-Lafuente","year":"2006","journal-title":"Arch Int Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrences of atrial fibrillation. Canadian trial of atrial fibrillation investigators","volume":"342","author":"Roy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib4","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.03.014_bib5","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Sotalol amiodarone atrial fibrillation efficacy trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","article-title":"Adverse effects of low dose amiodarone: a meta-analysis","volume":"30","author":"Vorperian","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.03.014_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.amjmed.2015.08.039","article-title":"Practical management guide for clinicians who treat patients with amiodarone","volume":"129","author":"Epstein","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib8","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/jce.12535","article-title":"Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials","volume":"25","author":"Cadrin-Tourigny","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.tcm.2016.03.014_bib9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehp100","article-title":"Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials","volume":"30","author":"Piccini","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2016.03.014_bib10","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.4065\/84.3.234","article-title":"Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: A meta-analysis","volume":"84","author":"Doyle","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2016.03.014_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ahj.2015.07.023","article-title":"Amiodarone and risk of death in contemporary patients with atrial fibrillation: Findings from the retrospective evaluation and assessment of therapies in AF study","volume":"170","author":"Ullal","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2016.03.014_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.hrthm.2014.03.006","article-title":"Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial","volume":"11","author":"Steinberg","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2016.03.014_bib14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2014.07.967","article-title":"Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation","volume":"64","author":"Flaker","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.03.014_bib15","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/eurheartj\/ehv201","article-title":"Edoxaban vs warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMA 48 trial","volume":"36","author":"Steffel","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2016.03.014_bib16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: The DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2010","journal-title":"J Cardiovasc Electrophys"},{"key":"10.1016\/j.tcm.2016.03.014_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/europace\/euq450","article-title":"mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone for the management of atrial fibrillation","volume":"13","author":"Freemantle","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2016.03.014_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib21","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib22","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.03.014_bib23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCEP.114.002046","article-title":"Interaction between digoxin and dronedarone in the PALLAS Trial","volume":"7","author":"Hohnloser","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.tcm.2016.03.014_bib24","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jacc.2014.02.601","article-title":"Safety of dronedarone in routine clinical care","volume":"63","author":"Friberg","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.03.014_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clinthera.2014.01.002","article-title":"Assessment of dronedarone utilization using US claims databases","volume":"36","author":"Wu","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.tcm.2016.03.014_bib26","first-page":"25","article-title":"Risk of cardiovascular events, stroke, congestive heart failure, interstitial lung disease, and acute liver injury: dronedarone versus amiodarone and other antiarrhythmics","volume":"6","author":"Gao","year":"2013","journal-title":"J Afib"},{"key":"10.1016\/j.tcm.2016.03.014_bib27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jacc.2010.08.600","article-title":"Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation","volume":"56","author":"Burashnikov","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.03.014_bib28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/CIRCEP.115.002856","article-title":"The harmony trial: combined ranolazine and dronedarone in the management of paroxysmal atrial fibrillation: mechanistic and therapeutic synergism","volume":"8","author":"Reiffel","year":"2015","journal-title":"Circ Arrhythmia Electrophysiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816300111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816300111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:41:30Z","timestamp":1655430090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173816300111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1050173816300111"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2016.03.014","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amiodarone and dronedarone: An update","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2016.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}